Showing 2681-2690 of 5771 results for "".
- Formycon Expands Global Reach of Eylea Biosimilar FYB203 with Licensing Deals in Australia and Latin Americahttps://modernod.com/news/formycon-expands-global-reach-of-eylea-biosimilar-fyb203-with-licensing-deals-in-australia-and-latin-america/2484186/Formycon AG announced that its licensing partner Klinge Biopharma, the exclusive global commercialization rights holder for Formycon’s Eylea¹ biosimilar FYB203 (aflibercept), has signed two new exclusive agreements to broaden the product’s internat
- Heru Surpasses One Million Eyes Tested on Its AI-Powered Wearable Vision Diagnostics Platformhttps://modernod.com/news/heru-surpasses-one-million-eyes-tested-on-its-ai-powered-wearable-vision-diagnostics-platform/2484185/Heru announced that it has surpassed 1 million eyes tested on its wearable platform. Founded out of the Bascom Palmer Eye Institute, Heru's AI-driven platform replaces multiple pieces of traditional diagnostic equ
- Y.ora Vision and Eyexora Global Partner with SERI to Advance New MIGS Platform for Glaucomahttps://modernod.com/news/yora-vision-and-eyexora-global-partner-with-seri-to-advance-new-migs-platform-for-glaucoma/2484184/Y.ora Vision, a newly formed ophthalmic medical device company, announced the signing of a licensing agreement between the Singapore Eye Research Institute (SERI) and Eyexora Global to advance a next-generation minimally invasive surgical device for the treatment o
- EssilorLuxottica Acquires RetinAI, Maker of AI and Data Management Technologyhttps://modernod.com/news/essilorluxottica-acquires-retinai-maker-of-ai-and-data-management-technology/2484183/EssilorLuxottica announced it is acquiring Ikerian AG, a Swiss health technology company operating under the RetinAI brand. Financial terms of the deal were not disclosed.
- Avisi Technologies Receives FDA Approval to Study Novel Approach to Glaucoma Treatmenthttps://modernod.com/news/avisi-technologies-receives-fda-approval-to-study-novel-approach-to-glaucoma-treatment/2484182/Avisi Technologies announced that the FDA has approved an investigational device exemption (IDE) for its glaucoma treatment device, VisiPlate. This milestone paves the way for the company’s SAPPHIRE clinical trial, which will evaluate the device in patie
- FDA Clears Complement Therapeutics’ IND Application for CTx001 Gene Therapy in GAhttps://modernod.com/news/fda-clears-complement-therapeutics-ind-application-for-ctx001-gene-therapy-in-ga/2484178/Complement Therapeutics has announced that the FDA has cleared its investigational new drug (IND) application for CTx001, the company’s lead gene therapy candidate. The clearance paves the way for the initiation of Opti-GAIN, a phase 1/2 clinic
- Johnson & Johnson Marks 100,000 US Implants of Tecnis Odyssey IOL; Showcases Innovations at AAO 2025https://modernod.com/news/johnson-johnson-marks-100000-us-implants-of-tecnis-odyssey-iol-and-showcases-innovations-at-aao-2025/2484177/Johnson & Johnson announced that its Tecnis Odyssey IOL has now been implanted in 100,000 eyes since its 2024 launch. The company will highlight this milestone alongside new data presentations and technology showcases
- BVI Receives FDA Approval for Finevision HP Trifocal IOLhttps://modernod.com/news/bvi-receives-fda-approval-for-finevision-hp-trifocal-iol/2484174/BVI announced that the FDA has approved its Finevision HP trifocal IOL. According to BVI, Finevision HP was the world’s first trifocal IOL, with more than 15 years of clinical success a
- Konan Medical Receives CE Marking for ObjectiveFIELD Analyzer (OFA)https://modernod.com/news/konan-medical-receives-ce-marking-for-objectivefield-analyzer-ofa/2484170/Konan Medical USA announced that its objectiveFIELD Analyzer (OFA) has received CE Marking under the European Medical Device Regulation (MDR). The CE Mark enables Konan Medical to offer its next-generation perimetry solution to healthcare providers throug
- Oculus Smartfield Perimeter Launches Aboard the International Space Station to Support Vision Researchhttps://modernod.com/news/oculus-smartfield-perimeter-launches-aboard-the-international-space-station-to-support-vision-research/2484168/Oculus announced that its Smartfield perimeter has successfully launched aboard the International Space Station (ISS) to support research on Spaceflight Associated Neuro-ocular Syndrome (SANS)—a condition known to affect astronauts’ vision during l